General Hospital Psychiatry
Volume 27, Issue 5 , Page 372 , September 2005

Aripiprazole treatment for psychosis associated with Friedreich's ataxia

References 

  1. Victor M, Ropper AH. Principles of neurology. In: 7th ed.. New York: McGraw-Hill; 2001;p. 1145–1147
  2. Lishman WA. Organic psychiatry, the psychological consequences of cerebral disorder. In: 3rd ed.. Oxford: Blackwell Scientific Publications; 1998;p. 705–706
  3. Salbenblatt M, Buzan RD, Dubovsky SL. Risperidone treatment for psychosis in end-stage Friedreich's ataxia. Am J Psychiatry. 2000;157(2):303
  4. White M, Lalonde R, Botez-Marquard T. Neuropsychologic and neuropsychiatric characteristics of patients with Friedreich's ataxia. Acta Neurol Scand. 2000;102:222–226
  5. Li Z, Ichikawa J, Dai J, Meltzer HY. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol. 2004;493(1–3):75–83

PII: S0163-8343(05)00068-X

doi: 10.1016/j.genhosppsych.2005.05.004

General Hospital Psychiatry
Volume 27, Issue 5 , Page 372 , September 2005

Article Tools